AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
OXALIPLATINE in Tunisia
22 products registered with DPM — 0 active, 22 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OXALIPLATIN AqVida Solution injectable pour perfusion / 5 mg/ml (100 mg) | 19463022H | AQVIDA GMBH | expired | 5 Aug 2019 |
| OXALIPLATIN AqVida Solution injectable pour perfusion / 5 mg/ml (50 mg) | 19463021H | AQVIDA GMBH | expired | 2 Aug 2019 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (100 mg) | 3153182H | FRESENIUS KABI FRANCE | expired | 24 Jul 2019 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (50 mg) | 3153181H | FRESENIUS KABI FRANCE | expired | 24 Jul 2019 |
| OXALIPLATIN ACCORD Solution injectable pour perfusion / 5 mg/ml (50 mg/10ml) | 16923032H | ACCORD HEALTHCARE LTD | expired | 4 Jan 2017 |
| OXALIPLATIN ACCORD Solution injectable pour perfusion / 5 mg/ml (100 mg/20ml) | 16923031H | ACCORD HEALTHCARE LTD | expired | 4 Jan 2017 |
| CYTOXALINE Solution injectable pour perfusion / 50 mg/10 ml | 9383032H | CYTOPHARMA | expired | 18 Jul 2016 |
| CYTOXALINE Solution injectable pour perfusion / 100 mg/20 ml | 9383031H | CYTOPHARMA | expired | 18 Jul 2016 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (50 mg) | 13923032H | FRESENIUS KABI ONCOLOGY PLC | expired | 20 Feb 2014 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (100 mg) | 13923031H | FRESENIUS KABI ONCOLOGY PLC | expired | 20 Feb 2014 |
| OXALIPLATINE VIATRIS Pdre p.prep.injectable / 5 mg/ml (50 mg) | 4923192H | VIATRIS SANTE | expired | 13 Jul 2011 |
| OXALIPLATINE VIATRIS Pdre p.prep.injectable / 5 mg/ml (100 mg) | 4923191H | VIATRIS SANTE | expired | 13 Jul 2011 |
| XALIPLAT 50 Pdre p.prep.injectable / 50 mg | 12213031H | Laboratorios Richmond S.A.C.I.F | expired | 27 Jul 2010 |
| GOXYRAL Pdre p.prep.injectable / 50 mg | 12273012H | ERIOCHEM | expired | 27 Jul 2010 |
| GOXYRAL Pdre p.prep.injectable / 100 mg | 12273011H | ERIOCHEM | expired | 27 Jul 2010 |
| XALIPLAT 100 Pdre p.prep.injectable / 100 mg | 12213032H | Laboratorios Richmond S.A.C.I.F | expired | 27 Jul 2010 |
| OXALIPLATIN ACTAVIS Pdre p.prep.injectable / 5 mg/ml (100 mg) | 12963022H | ACTAVIS SRL ROMANIA | expired | 19 Jul 2010 |
| OXALIPLATIN HOSPIRA Solution injectable pour perfusion / 5 mg/ml (100mg) | 13613012H | HOSPIRA UK Limited | expired | 19 Jul 2010 |
| OXALIPLATIN HOSPIRA Solution injectable pour perfusion / 5 mg/ml (50 mg) | 13613011H | HOSPIRA UK Limited | expired | 19 Jul 2010 |
| OXALIPLATIN ACTAVIS Pdre p.prep.injectable / 5 mg/ml (50 mg) | 12963021H | ACTAVIS SRL ROMANIA | expired | 19 Jul 2010 |
| OXALIPLATIN EBEWE Pdre p.prep.injectable / 5 mg/ml (50 mg) | 6943151H | EBEWE Pharma | expired | 27 Aug 2007 |
| OXALIPLATIN EBEWE Pdre p.prep.injectable / 5 mg/ml (100 mg) | 6943152H | EBEWE Pharma | expired | 25 Aug 2007 |
OXALIPLATINE — DPM Registration Details
DPM (Tunisia) has 22 registered products containing OXALIPLATINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track OXALIPLATINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.